scPharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

Scpharmaceuticals

10/05/2023 22:58

* scPharmaceuticals Inc  SCPH.OQ  reported a quarterly
adjusted
loss of 30 cents​​ per share for the quarter ended in March. The
mean expectation of five analysts for the quarter was for a loss
of 36 cents per share.
    * Revenue was $2.06 million​; analysts expected $1.37
million. 
    * scPharmaceuticals Inc's reported EPS for the quarter was a
loss
of 30 cents​.
    * The mean earnings estimate of analysts had risen by
about 9.9%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates 
    * scPharmaceuticals Inc shares had risen by 24.3% this
quarter and
gained 57.2% so far this year.
    * The company reported a quarterly loss of $11.21 million.
    * Wall Street's median 12-month price target for
scPharmaceuticals
Inc is $17.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
10 at 09:58 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.36          -0.30          Beat
 Dec. 31 2022      -0.39          -0.30          Beat
 Sep. 30 2022      -0.38          -0.37          Beat
 Jun. 30 2022      -0.30          -0.35          Missed